(VIANEWS) – NAVAMEDIC (NAVA.OL), FBD HOLDINGS PLC (EG7.IR), ABC ARBITRAGE (ABCA.PA) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| NAVAMEDIC (NAVA.OL) | 11.61% | 2023-11-01 08:41:18 |
| FBD HOLDINGS PLC (EG7.IR) | 8.62% | 2023-10-30 08:22:28 |
| ABC ARBITRAGE (ABCA.PA) | 6.79% | 2023-11-01 08:44:30 |
| BARBARA BUI (BUI.PA) | 4.08% | 2023-10-31 09:00:10 |
| AMG (AMG.AS) | 3.28% | 2023-11-01 08:00:26 |
| BOIRON (BOI.PA) | 2.77% | 2023-11-01 09:00:29 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. NAVAMEDIC (NAVA.OL)
11.61% Foward Dividend Yield
NAVAMEDIC’s last close was kr38.90, 11.39% below its 52-week high of kr43.90. Intraday change was 0.52%.
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 33.05. Meaning, the purchaser of the share is investing kr33.05 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 454.46M for the twelve trailing months.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 13, 2010, the estimated forward annual dividend yield is 11.61%.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr39.00 at 11:50 EST, way below its 52-week high of kr43.90 and way higher than its 52-week low of kr31.00.
More news about NAVAMEDIC.
2. FBD HOLDINGS PLC (EG7.IR)
8.62% Foward Dividend Yield
FBD HOLDINGS PLC’s last close was €11.55, 23% under its 52-week high of €15.00. Intraday change was -1.69%.
FBD Holdings plc, through its subsidiaries, engages in the underwriting of general insurance to farmers, private individuals, and business owners in Ireland. The company operates in two segments, Underwriting and Financial Services. It offers car, home, travel, life and pension, business, farm, and business insurance products, as well as insurance related to motor, fire, liability, and other damage to property. The company also provides investment, pension brokerage, and employee services; and engages in re-insurance activities. FBD Holdings plc was founded in 1969 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, FBD HOLDINGS PLC has a trailing twelve months EPS of €1.76.
PE Ratio
FBD HOLDINGS PLC has a trailing twelve months price to earnings ratio of 6.62. Meaning, the purchaser of the share is investing €6.62 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.11%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.5%, now sitting on 366.34M for the twelve trailing months.
Volume
Today’s last reported volume for FBD HOLDINGS PLC is 351 which is 98.53% below its average volume of 23942.
Volatility
FBD HOLDINGS PLC’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.11%, a negative 0.30%, and a positive 1.44%.
FBD HOLDINGS PLC’s highest amplitude of average volatility was 1.82% (last week), 1.57% (last month), and 1.44% (last quarter).
Moving Average
FBD HOLDINGS PLC’s worth is under its 50-day moving average of €12.51 and below its 200-day moving average of €12.77.
More news about FBD HOLDINGS PLC.
3. ABC ARBITRAGE (ABCA.PA)
6.79% Foward Dividend Yield
ABC ARBITRAGE’s last close was €4.72, 33.52% below its 52-week high of €7.10. Intraday change was -1.03%.
ABC arbitrage SA, together with its subsidiaries, engages in the development of arbitrage strategies for liquid assets worldwide. It develops liquidity, statistical, risk, and derivatives arbitrage strategies; and provides asset and portfolio management services. The company was incorporated in 1995 and is based in Paris, France.
Earnings Per Share
As for profitability, ABC ARBITRAGE has a trailing twelve months EPS of €0.37.
PE Ratio
ABC ARBITRAGE has a trailing twelve months price to earnings ratio of 12.93. Meaning, the purchaser of the share is investing €12.93 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.12%.
More news about ABC ARBITRAGE.
4. BARBARA BUI (BUI.PA)
4.08% Foward Dividend Yield
BARBARA BUI’s last close was €9.60, 8.57% under its 52-week high of €10.50. Intraday change was 0%.
Barbara Bui SA engages in the manufacture, marketing, and sale of ready-to-wear clothing and accessories for women in France and internationally. The company offers coats, jackets, tops and shirts, T-shirts, mesh, pants, dresses and skirts, leather products, and tailored cloths; and accessories, such as shoes, bags, scarves, and belts. It offers its products through wholesale distributors, as well as online and offline stores. The company was incorporated in 1982 and is based in Paris, France.
Earnings Per Share
As for profitability, BARBARA BUI has a trailing twelve months EPS of €1.04.
PE Ratio
BARBARA BUI has a trailing twelve months price to earnings ratio of 9.23. Meaning, the purchaser of the share is investing €9.23 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 125.51%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.6%, now sitting on 11.45M for the twelve trailing months.
Volatility
BARBARA BUI’s last week, last month’s, and last quarter’s current intraday variation average was 16.36%, 3.24%, and 16.48%.
BARBARA BUI’s highest amplitude of average volatility was 16.36% (last week), 11.82% (last month), and 16.48% (last quarter).
Yearly Top and Bottom Value
BARBARA BUI’s stock is valued at €9.60 at 11:50 EST, under its 52-week high of €10.50 and way above its 52-week low of €6.30.
More news about BARBARA BUI.
5. AMG (AMG.AS)
3.28% Foward Dividend Yield
AMG’s last close was €24.61, 50.77% below its 52-week high of €49.99. Intraday change was 0.04%.
AMG Critical Materials N.V. produces and sells engineered specialty metals and mineral products. It also provides vacuum furnace and hybrid energy storage systems to the transportation, infrastructure, energy, and specialty metals and chemicals markets. The company operates through three segments: AMG Clean Energy Materials, AMG Critical Minerals, and AMG Critical Materials Technologies. The AMG Clean Energy Materials segment operates and produces materials for infrastructure and energy storage solutions, as well as offers vanadium, lithium, and tantalum value chain elements. The AMG Critical Minerals segment operates and processes graphite, antimony, and silicon related metals. The AMG Critical Materials Technologies segment engages in vacuum furnace technology related activities. It primarily operates in the United States, China, Germany, Brazil, Italy, the United Kingdom, France, Canada, the Czech Republic, Japan, Austria, Thailand, India, Belgium, Mexico, South Korea, Poland, Turkey, Australia, Sweden, Spain, the Netherlands, Taiwan, Switzerland, Argentina, Singapore, Russia, Kazakhstan, Mozambique, and internationally. The company was formerly known as AMG Advanced Metallurgical Group N.V. and changed its name to AMG Critical Materials N.V. in May 2023. The company was incorporated in 2006 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, AMG has a trailing twelve months EPS of €6.53.
PE Ratio
AMG has a trailing twelve months price to earnings ratio of 3.77. Meaning, the purchaser of the share is investing €3.77 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 45.66%.
More news about AMG.
6. BOIRON (BOI.PA)
2.77% Foward Dividend Yield
BOIRON’s last close was €40.35, 28.58% below its 52-week high of €56.50. Intraday change was 2.16%.
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Earnings Per Share
As for profitability, BOIRON has a trailing twelve months EPS of €2.74.
PE Ratio
BOIRON has a trailing twelve months price to earnings ratio of 14.67. Meaning, the purchaser of the share is investing €14.67 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.64%.
More news about BOIRON.
